The Metrodora Institute, a multidisciplinary medical and research center with an ASC focused on improving diagnostics, therapeutics and cures for patients with neuroimmune axis disorders, has opened.
The Salt Lake City-based institute features a state-of-the-art ASC, two advanced laboratories and an infusion center, offering interventional medicine and specialized treatments for patients.
The institute, including the ASC, will see 20,000 patients a year, according to an April 19 press release.